V

Verastem
D

VSTM

5.33000
USD
0.04
(0.76%)
مغلق
حجم التداول
20,913
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
237,219,784
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADMA
    -0.630
    (-3.79%)
    16.000 USD
    C
    CTMX
    -0.00370
    (-0.44%)
    0.84340 USD
    E
    EXEL
    -0.340
    (-0.93%)
    36.200 USD
    I
    IMMP
    -0.00500
    (-0.26%)
    1.93500 USD
    I
    IONS
    -0.820
    (-2.54%)
    31.440 USD
    M
    MNOV
    0.00000
    (0.00%)
    1.88000 USD
    S
    SGEN
    0
    (0%)
    0 USD
    T
    TGTX
    0.380
    (1.30%)
    29.530 USD
    المزيد
الأخبار
المقالات

العنوان: Verastem

القطاع: Healthcare
الصناعة: Biotechnology
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.